Imvax
PrivateLast Round
Series C
Jan 29, 2025
Total Funding Raised
$203.5M
Momentum Score
25 /100
Company Overview
Imvax is a biotechnology company specializing in patient-specific vaccines and immunotherapy strategies aimed at treating malignant gliomas and other cancers with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imvax Comps
Public and private peers based on sector, stage, and business model.
Imvax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 29, 2025 | ||||
| VC Round | May 21, 2024 | ||||
| Series C Extension | Sep 6, 2023 | ||||
| Series C | Jul 16, 2020 | ||||
| Series B | May 28, 2019 | ||||
Series A | Jun 16, 2017 |
Imvax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetar Capital | Series C |
| Thomas Jefferson University | Series A |
| Invus Opportunities | Series C |
| TLP Investment Partners | Series C |
| TLP Invest | Series C |
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Series A |
| Ziff Capital Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2025
$29M round completed.
Imvax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imvax's valuation, stock price, and market status.
